Neogen (NEOG) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $12.27, +1.15% vs the prior close of $12.13.
- Volume 2.88M shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NEOG rises 1.2% to $12.27. Closed at $12.27, +1.15% vs the prior close of $12.13. Day range $11.85–$12.35, opened at $12.01.
NEOG daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — NEOG rises 1.2% to $12.27
- Closed at $12.27, +1.15% vs the prior close of $12.13. Day range $11.85–$12.35, opened at $12.01.
- Volume was 2.88M shares, 0.8x its 50-day average of 3.44M.
- Price is +1.0% vs its 50-day average ($12.15) and +20.2% vs its 200-day average ($10.21).
- 52-week range $5.37–$14.26; today's close sits at 78% of that range, 14.0% below the 52-week high.
Oct 14, 2026 — NEOG jumps 3.4% to $12.13
- Closed at $12.13, +3.41% vs the prior close of $11.73. Day range $11.50–$12.15, opened at $11.54.
- Volume was 3.35M shares, 1.0x its 50-day average of 3.43M.
- Price is +0.0% vs its 50-day average ($12.13) and +19.1% vs its 200-day average ($10.19).
- 52-week range $5.37–$14.26; today's close sits at 76% of that range, 14.9% below the 52-week high.
Oct 13, 2026 — NEOG dips 2.3% to $11.73
- Closed at $11.73, -2.25% vs the prior close of $12.00. Day range $11.71–$12.06, opened at $11.99.
- Volume was 2.34M shares, 0.7x its 50-day average of 3.49M.
- Price is -3.2% vs its 50-day average ($12.12) and +15.4% vs its 200-day average ($10.16).
- 52-week range $5.37–$14.26; today's close sits at 72% of that range, 17.7% below the 52-week high.
Oct 12, 2026 — NEOG rises 1.3% to $12.00, 3 up days in a row
- Closed at $12.00, +1.27% vs the prior close of $11.85. Day range $11.76–$12.11, opened at $11.99.
- Volume was 2.57M shares, 0.7x its 50-day average of 3.51M.
- Price is -1.0% vs its 50-day average ($12.13) and +18.4% vs its 200-day average ($10.14).
- 52-week range $5.37–$14.26; today's close sits at 75% of that range, 15.8% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — NEOG rises 1.2% to $11.85
- Closed at $11.85, +1.20% vs the prior close of $11.71. Day range $11.57–$12.11, opened at $11.71.
- Volume was 3.64M shares, 1.0x its 50-day average of 3.53M.
- Price is -2.3% vs its 50-day average ($12.13) and +17.2% vs its 200-day average ($10.11).
- 52-week range $5.37–$14.26; today's close sits at 73% of that range, 16.9% below the 52-week high.
Oct 8, 2026 — NEOG ends flat (+0.3%) to $11.71 on 2.5x normal volume
- Closed at $11.71, +0.26% vs the prior close of $11.68. Day range $11.13–$12.21, opened at $11.50.
- Volume was 8.67M shares, 2.5x its 50-day average of 3.42M — unusually heavy trading.
- Price is -3.4% vs its 50-day average ($12.12) and +16.1% vs its 200-day average ($10.09).
- 52-week range $5.37–$14.26; today's close sits at 71% of that range, 17.9% below the 52-week high.
Oct 7, 2026 — NEOG dips 2.3% to $11.68, a 1-month low on 4.0x normal volume
- Closed at $11.68, -2.34% vs the prior close of $11.96. Day range $11.37–$12.93, opened at $12.61.
- Volume was 12.96M shares, 4.0x its 50-day average of 3.21M — unusually heavy trading.
- Price is -3.3% vs its 50-day average ($12.07) and +16.0% vs its 200-day average ($10.07).
- 52-week range $5.37–$14.26; today's close sits at 71% of that range, 18.1% below the 52-week high.
- SEC filings that day: 10-Q, 8-K.
Oct 6, 2026 — NEOG slides 8.1% to $11.96 on 1.9x normal volume
- Closed at $11.96, -8.07% vs the prior close of $13.01. Day range $11.86–$13.22, opened at $13.06.
- Volume was 5.97M shares, 1.9x its 50-day average of 3.14M — unusually heavy trading.
- Price is -0.5% vs its 50-day average ($12.02) and +19.0% vs its 200-day average ($10.05).
- 52-week range $5.37–$14.26; today's close sits at 74% of that range, 16.1% below the 52-week high.
- SEC filings that day: 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 5, 2026 — NEOG jumps 7.1% to $13.01
- Closed at $13.01, +7.08% vs the prior close of $12.15. Day range $11.98–$13.06, opened at $12.02.
- Volume was 5.15M shares, 1.7x its 50-day average of 3.06M.
- Price is +8.7% vs its 50-day average ($11.97) and +29.8% vs its 200-day average ($10.02).
- 52-week range $5.37–$14.26; today's close sits at 86% of that range, 8.8% below the 52-week high.
Oct 2, 2026 — NEOG dips 0.7% to $12.15
- Closed at $12.15, -0.74% vs the prior close of $12.24. Day range $12.13–$12.50, opened at $12.40.
- Volume was 2.88M shares, 1.0x its 50-day average of 3.03M.
- Price is +2.1% vs its 50-day average ($11.90) and +21.6% vs its 200-day average ($9.99).
- 52-week range $5.37–$14.26; today's close sits at 76% of that range, 14.8% below the 52-week high.
NEOG latest news & SEC filings
Every SEC filing by or about NEOG in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Nassif Mikheal bought 505 shares at $11.95 (≈$6.03K) on Oct 9, 2026; now holds 1,579
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Aug 31, 2026:
- Revenue: $222.80M (prior year $209.20M) (+6.5% vs Aug 31, 2025)
- Net income: -$11.90M (prior year $36.30M) (loss widened vs Aug 31, 2025)
- Diluted EPS: -$0.05 (prior year $0.17) (loss widened vs Aug 31, 2025)
Oct 7, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Oct 6, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Woteki Catherine E received an award of 9,804 shares at $12.24 (≈$120.00K) on Oct 1, 2026; now holds 28,921
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wainer Andrea F received an award of 9,804 shares at $12.24 (≈$120.00K) on Oct 1, 2026; now holds 11,834
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Rodriguez Rafael A received an award of 9,804 shares at $12.24 (≈$120.00K) on Oct 1, 2026; now holds 30,625
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Pelossof Avi received an award of 9,804 shares at $12.24 (≈$120.00K) on Oct 1, 2026; now holds 9,804
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gupta Aashima received an award of 9,804 shares at $12.24 (≈$120.00K) on Oct 1, 2026; now holds 37,594
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · DEFA14A — Additional proxy materials
Additional proxy materials
Aug 21, 2026 · ARS — Annual report to shareholders
Annual report to shareholders
Aug 21, 2026 · DEFA14A — Additional proxy materials
Additional proxy materials
Aug 21, 2026 · DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 7, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 30, 2026 · 10-K — Annual report (audited full-year financial statements and business review)
Annual report (audited full-year financial statements and business review)
Fiscal year ended May 31, 2026:
- Revenue: $870.40M (prior year $894.70M) (-2.7% vs May 31, 2025)
- Net income: -$7.90M (prior year -$1.09B) (loss narrowed vs May 31, 2025)
- Diluted EPS: -$0.04 (prior year -$5.03) (loss narrowed vs May 31, 2025)
Things to know before you trade NEOG
- Last results release: Oct 6, 2026 (8-K Item 2.02). Previous ones: Jul 30, 2026, Apr 9, 2026, Jan 8, 2026. Based on that rhythm, the next report is likely around Jan 5, 2027 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.66% (largest 8.1%).
- Liquidity: about 5.59M shares (≈$68.61M) trade per day on average.
- 52-week position: $12.27 vs a range of $5.37–$14.26 (78% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 6 open-market buys, 0 sales; latest: Mikheal Nassif bought 370 shares on Aug 4, 2026.
- Latest filings: 10-Q Oct 7, 2026; 8-K Oct 7, 2026; 8-K Oct 6, 2026.
- Share count: 218.31M shares outstanding (Aug 31, 2026), +0.5% vs a year earlier.
- Listing: Nasdaq · industry: In Vitro & In Vivo Diagnostic Substances.
NEOG market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 12.01 | 12.35 | 11.85 | 12.27 | 2.88M |
| Oct 14, 2026 | 11.54 | 12.15 | 11.50 | 12.13 | 3.35M |
| Oct 13, 2026 | 11.99 | 12.06 | 11.71 | 11.73 | 2.34M |
| Oct 12, 2026 | 11.99 | 12.11 | 11.76 | 12.00 | 2.57M |
| Oct 9, 2026 | 11.71 | 12.11 | 11.57 | 11.85 | 3.64M |
| Oct 8, 2026 | 11.50 | 12.21 | 11.13 | 11.71 | 8.67M |
| Oct 7, 2026 | 12.61 | 12.93 | 11.37 | 11.68 | 12.96M |
| Oct 6, 2026 | 13.06 | 13.22 | 11.86 | 11.96 | 5.97M |
| Oct 5, 2026 | 12.02 | 13.06 | 11.98 | 13.01 | 5.15M |
| Oct 2, 2026 | 12.40 | 12.50 | 12.13 | 12.15 | 2.88M |
| Oct 1, 2026 | 12.68 | 12.82 | 12.19 | 12.24 | 2.97M |
| Sep 30, 2026 | 12.58 | 13.11 | 12.51 | 12.80 | 6.89M |
| Sep 29, 2026 | 13.74 | 13.87 | 12.71 | 12.73 | 14.82M |
| Sep 28, 2026 | 13.75 | 13.85 | 13.42 | 13.72 | 7.57M |
| Sep 25, 2026 | 13.68 | 13.86 | 13.38 | 13.76 | 5.22M |
| Sep 24, 2026 | 13.48 | 14.01 | 13.46 | 13.66 | 3.83M |
| Sep 23, 2026 | 14.21 | 14.26 | 13.50 | 13.57 | 3.68M |
| Sep 22, 2026 | 13.62 | 14.18 | 13.61 | 13.98 | 4.62M |
| Sep 21, 2026 | 13.12 | 13.72 | 12.96 | 13.61 | 4.40M |
| Sep 18, 2026 | 12.75 | 13.07 | 12.71 | 13.00 | 7.44M |
About Neogen
Neogen (NEOG) is listed on the Nasdaq and classified by the SEC under “In Vitro & In Vivo Diagnostic Substances”. Its business address is in LANSING, MI. State of incorporation: MI. Fiscal year ends May 31. SEC CIK 711377.
NEOG board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| William T Boehm | Director | Oct 28, 2025 |
| James C Borel | Director | Oct 29, 2025 |
| Thierry Bernard | Director | Oct 27, 2025 |
| Jeffrey D Capello | Director | Oct 29, 2025 |
| Ronald D Green | Director | Oct 29, 2025 |
| Aashima Gupta | Director | Oct 29, 2025 |
| Mikheal Nassif | CEO | Aug 20, 2026 |
| Avi Pelossof | Director | Oct 28, 2025 |
| Rafael A Rodriguez | Director | Oct 28, 2025 |
| James P Tobin | Director | Oct 28, 2025 |
| Andrea F Wainer | Director | Oct 27, 2025 |
| Catherine E Woteki | Director | Oct 28, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| John Edward Adent | Former CEO | Oct 28, 2025 |
| Douglas Edward Jones | Former COO | Oct 28, 2025 |
| John Patrick Moylan | Chief Accounting Officer | Aug 20, 2026 |
| David H. Naemura | Former CFO | Dec 2, 2025 |
| Mikheal Nassif | CEO | Aug 20, 2026 |
| Tamara A. Ranalli | Senior Vice President | Aug 14, 2026 |
| Richard Bryan Riggsbee | CFO | Aug 14, 2026 |
| Amy M Rocklin | Former Chief Legal Officer | May 19, 2026 |
| Jennifer Evans Stacey | Chief Legal Officer | Aug 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 4, 2026 | Mikheal Nassif | Buy | 370 | $11.81 |
| Feb 17, 2026 | Mikheal Nassif | Buy | 23 | $10.94 |
| Feb 2, 2026 | Mikheal Nassif | Buy | 24 | $10.00 |
| Jan 26, 2026 | Mikheal Nassif | Buy | 25 | $9.86 |
| Jan 16, 2026 | Mikheal Nassif | Buy | 137 | $9.33 |
| Nov 3, 2025 | Mikheal Nassif | Buy | 177 | $6.25 |
NEOG financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| May 31, 2026 | $870.40M | $-7.90M | -0.04 | $83.20M |
| May 31, 2025 | $894.70M | $-1.09B | -5.03 | $58.20M |
| May 31, 2024 | $924.20M | $-9.40M | -0.04 | $35.30M |
| May 31, 2023 | $822.45M | $-22.87M | -0.12 | $41.03M |
| May 31, 2022 | $527.16M | $48.31M | 0.45 | $68.04M |
Latest balance sheet: total assets $3.30B, total liabilities $1.22B, cash $172.00M (as of Aug 31, 2026).
NEOG earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 6, 2026 | 8-K Item 2.02 (results) | $11.96 |
| Jul 30, 2026 | 8-K Item 2.02 (results) | $11.53 |
| Apr 9, 2026 | 8-K Item 2.02 (results) | $10.04 |
| Jan 8, 2026 | 8-K Item 2.02 (results) | $9.71 |
| Oct 9, 2025 | 8-K Item 2.02 (results) | $6.78 |
| Jul 29, 2025 | 8-K Item 2.02 (results) | $4.83 |
| Apr 9, 2025 | 8-K Item 2.02 (results) | $5.02 |
| Jan 10, 2025 | 8-K Item 2.02 (results) | $12.36 |
| Oct 10, 2024 | 8-K Item 2.02 (results) | — |
| Jul 30, 2024 | 8-K Item 2.02 (results) | — |
| Apr 9, 2024 | 8-K Item 2.02 (results) | — |
| Jan 9, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · In Vitro & In Vivo Diagnostic Substances
Idexx Laboratories (IDXX)Lantheus (LNTH)Intellia Therapeutics (NTLA)Celldex Therapeutics (CLDX)QuidelOrtho (QDEL)Achieve Life Sciences (ACHV)Myriad Genetics (MYGN)Alpha Teknova (TKNO)Insight Molecular Diagnostics (IMDX)Volitionrx (VNRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on NEOG
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.